A member of the Robert H. Lurie Comprehensive Cancer Center, which was recently awarded an $11.5 million Specialized Program of Research Excellence (SPORE) grant, Rimas Lukas, MD, discusses immunotherapeutic approaches for the treatment of high-grade gliomas. In this video, Dr. Lukas shares results of a promising Phase 1 clinical trial and other projects underway.

свернуть